(Q83824669)
Statements
Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells (English)
Ranjita Misra
scientific article published on 15 April 2011